These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35240310)

  • 1. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.
    Numata M; Voelker DR
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159139. PubMed ID: 35240310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids.
    Numata M; Kandasamy P; Voelker DR
    Immunol Rev; 2023 Aug; 317(1):166-186. PubMed ID: 37144896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid regulation of innate immunity and respiratory viral infection.
    Voelker DR; Numata M
    J Biol Chem; 2019 Mar; 294(12):4282-4289. PubMed ID: 30733339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium.
    Numata M; Sajuthi S; Bochkov YA; Loeffler J; Everman J; Vladar EK; Cooney RA; Reinhardt RL; Liu AH; Seibold MA; Voelker DR
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models.
    Numata M; Mitchell JR; Tipper JL; Brand JD; Trombley JE; Nagashima Y; Kandasamy P; Chu HW; Harrod KS; Voelker DR
    J Biol Chem; 2020 Feb; 295(6):1704-1715. PubMed ID: 31882535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.
    Kuronuma K; Mitsuzawa H; Takeda K; Nishitani C; Chan ED; Kuroki Y; Nakamura M; Voelker DR
    J Biol Chem; 2009 Sep; 284(38):25488-500. PubMed ID: 19584052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.
    Numata M; Chu HW; Dakhama A; Voelker DR
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):320-5. PubMed ID: 20080799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of phospholipid-modified lung surfactant in vitro and in a neonatal ARDS model reveals anti-inflammatory potential and surfactant lipidome signatures.
    Kupsch S; Eggers LF; Spengler D; Gisch N; Goldmann T; Fehrenbach H; Stichtenoth G; Krause MF; Schwudke D; Schromm AB
    Eur J Pharm Sci; 2022 Aug; 175():106216. PubMed ID: 35618202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Applications of Pulmonary Surfactant Lipids in the Host Defence Against Respiratory Viral Infections.
    Ji J; Sun L; Luo Z; Zhang Y; Xianzheng W; Liao Y; Tong X; Shan J
    Front Immunol; 2021; 12():730022. PubMed ID: 34646269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylglycerol suppresses influenza A virus infection.
    Numata M; Kandasamy P; Nagashima Y; Posey J; Hartshorn K; Woodland D; Voelker DR
    Am J Respir Cell Mol Biol; 2012 Apr; 46(4):479-87. PubMed ID: 22052877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling.
    Kandasamy P; Numata M; Berry KZ; Fickes R; Leslie CC; Murphy RC; Voelker DR
    J Lipid Res; 2016 Jun; 57(6):993-1005. PubMed ID: 27095543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation.
    Viviano CJ; Bakewell WE; Dixon D; Dethloff LA; Hook GE
    Biochim Biophys Acta; 1995 Dec; 1259(3):235-44. PubMed ID: 8541330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in phospholipid components of pulmonary surfactant in experimental influenza infection and their correction by remantadin and deitiforine].
    Kazinets ON; Amvros'eva TV; Rusiaev VA
    Vopr Virusol; 2002; 47(2):22-5. PubMed ID: 12046462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol inhibits respiratory syncytial virus infection.
    Numata M; Kandasamy P; Nagashima Y; Fickes R; Murphy RC; Voelker DR
    J Lipid Res; 2015 Mar; 56(3):578-587. PubMed ID: 25561461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
    Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A
    Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
    Ma Q; Huang W; Zhao J; Yang Z
    J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
    Du X; Zuo X; Meng F; Han C; Ouyang W; Han Y; Gu Y; Zhao X; Xu F; Qin FX
    Cell Prolif; 2021 Jan; 54(1):e12953. PubMed ID: 33211371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study.
    Spengler D; Winoto-Morbach S; Kupsch S; Vock C; Blöchle K; Frank S; Rintz N; Diekötter M; Janga H; Weckmann M; Fuchs S; Schromm AB; Fehrenbach H; Schütze S; Krause MF
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L32-L53. PubMed ID: 28860142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection.
    Numata M; Nagashima Y; Moore ML; Berry KZ; Chan M; Kandasamy P; Peebles RS; Murphy RC; Voelker DR
    J Lipid Res; 2013 Aug; 54(8):2133-2143. PubMed ID: 23749985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.